Who Exports Nilotinib from India — 45 Suppliers Behind a $1.2M Market
India's nilotinib export market is supplied by 45 active exporters who collectively shipped $1.2M across 193 shipments. JODAS EXPOIM PRIVATE LIMITED leads with a 88.4% market share, followed by VAMA HEALTH WORLD LLP and UNOTEX PHARMA LLP. The top 5 suppliers together control 94.2% of total export value, reflecting a concentrated market structure.
Top Nilotinib Exporters from India — Ranked by Export Value
JODAS EXPOIM PRIVATE LIMITED is the leading nilotinib exporter from India, holding a 88.4% share of the $1.2M market across 193 shipments from 45 exporters. The top 5 suppliers — JODAS EXPOIM PRIVATE LIMITED, VAMA HEALTH WORLD LLP, UNOTEX PHARMA LLP, DOSHI MEDICARE PRIVATE LIMITED, EXGEN CARE PRIVATE LIMITED — collectively control 94.2% of total export value, indicating a highly concentrated market. Individual shares are: JODAS EXPOIM PRIVATE LIMITED (88.4%), VAMA HEALTH WORLD LLP (2.4%), UNOTEX PHARMA LLP (1.7%), DOSHI MEDICARE PRIVATE LIMITED (1.1%), EXGEN CARE PRIVATE LIMITED (0.6%).
Top Nilotinib Exporters from India
Ranked by export value · 45 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | JODAS EXPOIM PRIVATE LIMITED NILOTINIB CAPSULES 200MG NOSNILOTINIB CAPSULES 150MG NOSNINLIB CAP | $1.1M | 1 | 88.4% |
| 2 | VAMA HEALTH WORLD LLP | $30.5K | 2 | 2.4% |
| 3 | UNOTEX PHARMA LLP | $21.2K | 1 | 1.7% |
| 4 | DOSHI MEDICARE PRIVATE LIMITED PHARMACEUTICALS PRODUCTS KNILONAT 200 MG CAP NILOTINIB | $13.9K | 2 | 1.1% |
| 5 | EXGEN CARE PRIVATE LIMITED | $7.0K | 1 | 0.6% |
| 6 | ANR HEALTH CARE PRIVATE LIMITED | $2.4K | 1 | 0.2% |
| 7 | AXA PARENTERALS LIMITED TINICAP NILOTINIB CAP 200MG | $1.2K | 1 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Nilotinib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| JODAS EXPOIM PRIVATE LIMITED | Approved | Yes | Yes | 1 | FDA approval and WHO-GMP certification confirmed. |
| VAMA HEALTH WORLD LLP | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
| UNOTEX PHARMA LLP | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
| DOSHI MEDICARE PRIVATE LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
| EXGEN CARE PRIVATE LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
| ANR HEALTH CARE PRIVATE LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
| AXA PARENTERALS LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certification confirmed; no FDA listing. |
TransData Nexus reviewed the regulatory standing of 7 leading Nilotinib exporters from India. 1 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Nilotinib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturers, including Neuland Laboratories, which specializes in the development and production of APIs for various therapeutic segments. This robust infrastructure positions Hyderabad as a pivotal hub for sourcing high-quality APIs, such as Nilotinib.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region is home to several leading pharmaceutical companies that excel in producing finished dosage forms. The concentration of formulation expertise and manufacturing facilities in this area makes it a strategic location for the production of Nilotinib tablets and capsules, ensuring adherence to stringent quality standards.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. With its proximity to major ports and well-established logistics infrastructure, this region facilitates efficient distribution of pharmaceuticals to international markets. Companies operating here are adept at navigating global regulatory requirements, making it an advantageous location for exporting Nilotinib to various countries.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized for its favorable tax incentives, attracting numerous pharmaceutical manufacturers. The region offers benefits such as tax holidays and reduced excise duties, which can lower production costs. This cost-effectiveness, combined with a growing industrial base, makes Baddi-Nalagarh an appealing option for manufacturing Nilotinib, especially for cost-sensitive markets.
5Sourcing Recommendations
- Diversify Supplier Base: While Jodas Expoim Private Limited dominates Nilotinib exports, accounting for 88.4% of the total value, it's prudent to engage with multiple suppliers to mitigate risks associated with over-reliance on a single source.
- Evaluate Supplier Compliance: Given the regulatory scrutiny faced by Jodas Expoim Private Limited, including a seizure of antibiotics worth ₹1.33 crore in November 2024 due to labeling and packing violations, it's essential to assess suppliers' adherence to regulatory standards to ensure product integrity.
- Leverage Regional Strengths: Align sourcing strategies with the strengths of each pharmaceutical cluster. For instance, source APIs from Hyderabad's specialized manufacturers and formulations from the Ahmedabad-Vadodara hub to optimize quality and cost-efficiency.
- Monitor Export Destinations: With Sri Lanka accounting for 88.4% of Nilotinib exports, closely monitor market dynamics and regulatory changes in key destination countries to maintain and expand market share.
By strategically engaging with India's diverse pharmaceutical clusters and adhering to these recommendations, TransData Nexus can enhance its supply chain resilience and capitalize on the country's robust pharmaceutical manufacturing capabilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Nilotinib exporters from India
JODAS EXPOIM PRIVATE LIMITED — Regulatory action against Jodas Expoim for mislabeling antibiotics
In November 2024, the Telangana Drug Control Administration discovered that Jodas Expoim Pvt. Ltd. was exporting antibiotics to Russia under its own label, despite these being manufactured by other companies. The firm lacked the necessary manufacturing license for these antibiotics, leading to legal proceedings under Sections 18(c) and 17(B)(c) of the Drugs and Cosmetics Act, 1940. - IMPACT: This regulatory scrutiny may affect Jodas Expoim's export operations, potentially impacting its Nilotinib shipments.
Impact: This regulatory scrutiny may affect Jodas Expoim's export operations, potentially impacting its Nilotinib shipments.
Common Questions — Nilotinib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which nilotinib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, JODAS EXPOIM PRIVATE LIMITED leads with 12 recorded shipments worth $1.1M. VAMA HEALTH WORLD LLP (6 shipments) and UNOTEX PHARMA LLP (4 shipments) are also established high-volume exporters.
Q How many nilotinib manufacturers are there in India?
India has 45 active nilotinib exporters with a combined export market of $1.2M across 193 shipments to 30 countries. The top 5 suppliers hold 94.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for nilotinib from India?
Average FOB unit price: $44.82 per unit, ranging from $0.01 to $706.93. Average shipment value: $6.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 45 verified Indian exporters of Nilotinib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 193 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 30 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
193 Verified Shipments
45 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists